These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2957429)

  • 1. A urine inhibitor of interleukin 1 activity that blocks ligand binding.
    Seckinger P; Lowenthal JW; Williamson K; Dayer JM; MacDonald HR
    J Immunol; 1987 Sep; 139(5):1546-9. PubMed ID: 2957429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein.
    Carter DB; Deibel MR; Dunn CJ; Tomich CS; Laborde AL; Slightom JL; Berger AE; Bienkowski MJ; Sun FF; McEwan RN
    Nature; 1990 Apr; 344(6267):633-8. PubMed ID: 2139180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.
    Seckinger P; Williamson K; Balavoine JF; Mach B; Mazzei G; Shaw A; Dayer JM
    J Immunol; 1987 Sep; 139(5):1541-5. PubMed ID: 3040855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1.
    Mazzei GJ; Seckinger PL; Dayer JM; Shaw AR
    Eur J Immunol; 1990 Mar; 20(3):683-9. PubMed ID: 2138562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1 binding, internalization, and processing in a murine osteoblastic cell line, MC3T3.E1.
    Shelly JA; Laborde AL
    Eur Cytokine Netw; 1992; 3(5):469-75. PubMed ID: 1477298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internalization of interleukin 1 (IL 1) correlates with IL 1-induced IL 2 receptor expression and IL 2 secretion of EL4 thymoma cells.
    Von Hoegen I; Falk W; Kojouharoff G; Krammer PH
    Eur J Immunol; 1989 Feb; 19(2):329-34. PubMed ID: 2522880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor.
    Hannum CH; Wilcox CJ; Arend WP; Joslin FG; Dripps DJ; Heimdal PL; Armes LG; Sommer A; Eisenberg SP; Thompson RC
    Nature; 1990 Jan; 343(6256):336-40. PubMed ID: 2137200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for inhibitors of interleukin-1 based on the sequence of interleukin-1 receptor antagonist.
    Wieczorek Z; Kluczyk A; Slon-Usakiewicz JJ; Siemion IZ
    Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(4):123-9. PubMed ID: 9575352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1ra: properties and uses of an interleukin-1 receptor antagonist.
    Thompson RC; Dripps DJ; Eisenberg SP
    Agents Actions Suppl; 1991; 35():41-9. PubMed ID: 1838233
    [No Abstract]   [Full Text] [Related]  

  • 10. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.
    Dinarello CA; Thompson RC
    Immunol Today; 1991 Nov; 12(11):404-10. PubMed ID: 1838480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure function relationships for the IL 2 receptor system. III. Tac protein missing amino acids 102 to 173 (exon 4) is unable to bind IL 2: detection of spliced protein after L cell transfection.
    Neeper MP; Kuo LM; Kiefer MC; Robb RJ
    J Immunol; 1987 May; 138(10):3532-8. PubMed ID: 3033076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native interleukin 1 inhibitors.
    Larrick JW
    Immunol Today; 1989 Feb; 10(2):61-6. PubMed ID: 2526643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specific IL-1 inhibitor from the human M20 cell line is distinct from the IL-1 receptor antagonist.
    Barak V; Peritt D; Flechner I; Yanai P; Halperin T; Treves AJ; Dinarello CA
    Lymphokine Cytokine Res; 1991 Dec; 10(6):437-42. PubMed ID: 1839505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
    Burger D; Chicheportiche R; Giri JG; Dayer JM
    J Clin Invest; 1995 Jul; 96(1):38-41. PubMed ID: 7615809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
    Yoon DY; Dinarello CA
    J Immunol; 1998 Apr; 160(7):3170-9. PubMed ID: 9531272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotonicity of interleukin-1 receptor-ligand binding with respect to antagonist in the presence of decoy receptor.
    Gnacadja G; Shoshitaishvili A; Gresser MJ; Varnum B; Balaban D; Durst M; Vezina C; Li Y
    J Theor Biol; 2007 Feb; 244(3):478-88. PubMed ID: 17011587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of IL-1 activity by soluble IL-1 receptors.
    Kurrle R; Lauffer L; Röder J; Kanzy EJ; Enssle KH; Seiler FR
    Behring Inst Mitt; 1995 Jun; (96):45-57. PubMed ID: 7575352
    [No Abstract]   [Full Text] [Related]  

  • 18. A novel urinary sialoglycoprotein as the inhibitor of interleukin-1.
    Kabir S; Wigzell H
    Clin Exp Immunol; 1989 Jul; 77(1):89-96. PubMed ID: 2670348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the murine interleukin-1 receptor.
    Bird TA; Gearing AJ; Saklatvala J
    Dev Biol Stand; 1988; 69():83-91. PubMed ID: 2976006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of IL 1-induced fibroblast PGE2 production by a urine-derived IL 1 inhibitor.
    Korn JH; Brown KM; Downie E; Liao ZH; Rosenstreich DL
    J Immunol; 1987 May; 138(10):3290-4. PubMed ID: 3494764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.